Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors

Lung Cancer

Volumn 62, Issue 2, 2008, Pages 173-180

  Kalinichenko, Svetlana V ^a   Kopantzev, Eugene P ^b   Korobko, Elena V ^a,c   Palgova, Irina V ^a   Zavalishina, Larisa E ^d   Bateva, Maria V ^d   Petrov, Andrey N ^d   Frank, Georgii A ^d   Sverdlov, Eugene D ^b   Korobko, Igor V ^a,c  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c UNIVERSITY OF OSLO   (Norway)

^d P A Herzen Research Oncological Institute   (Russian Federation)

Author keywords

NSCLC; Pdcd4; Post translational regulation; Squamous cell carcinoma; Transcription

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PROGRAMMED CELL DEATH 4 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL LYSATE; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; NUCLEOTIDE SEQUENCE; PDCD4 GENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING;

EID: 55049140267     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.03.022     Document Type: Article

References (37)

1. Shibahara K., Asano M., Ishida Y., Aoki T., Koike T., and Honjo T. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166 (1995) 297-301
2. Difilippantonio S., Chen Y., Pietas A., Schluns K., Pacyna-Gengelbach M., Deutschmann N., et al. Gene expression profiles in human non-small and small-cell lung cancers. Eur J Cancer 39 (2003) 1936-1947
3. Chen Y., Knosel T., Kristiansen G., Pietas A., Garber M.E., Matsuhashi S., et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200 (2003) 640-646
4. Zhang H., Ozaki I., Mizuta T., Hamajima H., Yasutake T., Eguchi Y., et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25 (2006) 6101-6112
5. Matsuhashi S., Narisawa Y., Ozaki I., and Mizuta T. Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp Dermatol 16 (2007) 179-184
6. Gao F., Zhang P., Zhou C., Li J., Wang Q., Zhu F., et al. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol Rep 17 (2007) 123-128
7. Cmarik J.L., Min H., Hegamyer G., Zhan S., Kulesz-Martin M., Yoshinaga H., et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96 (1999) 14037-14042
8. Jansen A.P., Camalier C.E., and Colburn N.H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65 (2005) 6034-6041
9. Hilliard A., Hilliard B., Zheng S.J., Sun H., Miwa T., Song W., et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 177 (2006) 8095-8102
10. Jansen A.P., Camalier C.E., Stark C., and Colburn N.H. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3 (2004) 103-110
11. Afonja O., Juste D., Das S., Matsuhashi S., and Samuels H.H. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells Evidence for a role in apoptosis. Oncogene 23 (2004) 8135-8145
12. Hwang S.K., Jin H., Kwon J.T., Chang S.H., Kim T.H., Cho T.S., et al. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 14 (2007) 1353-1361
13. Wang Q., Sun Z., and Yang H.S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 27 (2008) 1527
14. Yang H.S., Matthews C.P., Clair T., Wang Q., Baker A.R., Li C.C.H., et al. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26 (2006) 1297-1306
15. Bitomsky N., Böhm M., and Klempnauer K.H. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23 (2004) 7484-7493
16. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20 (2001) 669-676
17. Yang H.S., Jansen A.P., Komar A.A., Zheng X., Merrick W.C., Costes S., et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23 (2003) 26-37
18. Leupold J.H., Yang H.S., Colburn N.H., Asangani I., Post S., and Allagayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26 (2007) 4550-4562
19. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene advance online publication, October 29, 2007; doi:10.1038/sj.onc.1210856.
20. Jin H., Kim T.H., Hwang S.K., Chang S.H., Kim H.W., Anderson H.K., et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther 5 (2006) 1041-1049
21. Göke R., Barth P., Schmidt A., Samans B., and Lankart-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287 (2006) C1541-C1546
22. Lankat-Buttgereit B., and Goke R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy?. Biol Cell 95 (2003) 515-519
23. Lankat-Buttgereit B., Lenschen B., Schmidt H., and Göke R. The action of Pdcd4 may be cell type specific: evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells. Apoptosis 13 (2007) 157-164
24. Yoshinaga H., Matsuhashi S., Fujiyama C., and Masaki Z. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49 (1999) 1067-1077
25. Schlichter U., Burk O., Worpenberg S., and Klempnauer K.H. The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20 (2001) 231-239
26. Palamarchuk A., Efanov A., Maximov V., Aqeilan R.I., Croce C.V., and Pekarsky Y. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65 (2005) 11282-11286
27. Azzoni L., Zatsepina O., Abebe B., Bennett I.M., Kanakaraj P., and Perussia B. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 161 (1998) 3493-3500
28. Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N., Sherman N.E., and Pagano M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science 314 (2006) 467-471
29. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), CSHL Press, Cold Spring Harbour
30. Chomczynski P., and Mackey K. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19 (1995) 942-945
31. Zhu Y.Y., Machleder E.M., Chenchik A., Li R., and Siebert P.D. Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques 30 (2001) 892-897
32. Liu D.W., Chen S.T., and Liu H.P. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J 26 (2005) 1002-1008
33. Green J.A., and Manson M.M. Production of polyclonal antiserum. In: Manson M.M. (Ed). Immunochemical protocols (1992), Humana Press, Totowa, New Jersey 1-6
34. Korobko I.V., Zavalishina L.E., Kiselev S.L., Raikhlin N.T., and Frank G.A. Proteinkinase MAK-V/Hunk as a possible dianostic and prognostic marker of human breast carcinoma. Arkh Patol 66 (2004) 6-9
35. He N., Li C., Zhang X., Sheng T., Chi S., Chen K., et al. Regulation of lung cancer cell growth and invasiveness by beta-TRCP. Mol Carcinog 42 (2005) 18-28
36. Uhlen M., Bjorling E., Agaton C., Szigyarto C.A., Amini B., Andersen E., et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomic 4 (2005) 1920-1932
37. Mudduluru G., Medved F., Grobholz R., Jost C., Gruber A., Leupold J.H., et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110 (2007) 1697-1707